This HTML5 document contains 45 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n12http://linked.opendata.cz/resource/drugbank/drug/DB03068/identifier/chebi/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n8http://linked.opendata.cz/resource/mesh/concept/
n11http://linked.opendata.cz/resource/drugbank/drug/DB03068/identifier/pdb/
n6http://bio2rdf.org/drugbank:
n13http://linked.opendata.cz/resource/drugbank/drug/DB03068/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n14http://linked.opendata.cz/resource/drugbank/drug/DB03068/identifier/pubchem-substance/
n16http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n10http://linked.opendata.cz/resource/drugbank/drug/DB03068/identifier/drugbank/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n7http://linked.opendata.cz/ontology/mesh/
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB03068
rdf:type
n3:Drug
n3:description
A chemically stable, cytidine analog that displays anti-tumor properties. Acts as a transition state analog inhibitor of cytidine deaminase by binding to the active size as covalent hydrates. Also shown to inhibit DNA methylation and tumor growth both in vitro and in vivo.
n3:group
experimental
owl:sameAs
n6:DB03068 n16:DB03068
dcterms:title
Zebularine
adms:identifier
n10:DB03068 n11:Z n12:46938 n13:100016 n14:46504541
n3:synonym
1-beta-D-ribofuranosylpyrimidin-2(1H)-one 1-beta-D-ribofuranosyl-2(1H)-pyrimidinone Pyrimidin-2-one ribonucleoside DHZ Pyrimidin-2-one beta-D-ribofuranoside pyrimidin-2-one beta-ribofuranoside
n7:hasConcept
n8:M0053562
n3:IUPAC-Name
n4:271B4BF2-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4BF8-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4BF7-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4BF4-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4BF5-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4BF6-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4BF0-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4BEE-363D-11E5-9242-09173F13E4C5 n4:271B4BF1-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4BEF-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4BFE-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4BFF-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4BF9-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4BFA-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4BFC-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4BFB-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4BFD-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
3690-10-6
n3:Bioavailability
n4:271B4C04-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4C06-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4C07-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4C03-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4C02-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4C05-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4BF3-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4C00-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4C01-363D-11E5-9242-09173F13E4C5